News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current OCX market cap is 62.63M. The company's latest EPS is USD -3.6034 and P/E is -0.85.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | -10.87M | 176k | 104k | 115k | 5.76M |
| Operating Income | -22.94M | -9.1M | -4.63M | -13.52M | -33.63M |
| Net Income | -16.2M | -9.13M | -4.53M | -13.49M | -33.51M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.23M | 7.73M | 31.98M | 7.27M | 6.16M |
| Operating Income | -31.26M | -74.48M | -18M | -23.85M | -60.87M |
| Net Income | -29.93M | -64.1M | -73.42M | -28.72M | -60.66M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 74.89M | 70.97M | 74.72M | 70.22M | 35.08M |
| Total Liabilities | 49.3M | 54.05M | 52.02M | 60.51M | 47.36M |
| Total Equity | 20.47M | 11.59M | 22.7M | 9.71M | -12.27M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 55.42M | 159.56M | 100.09M | 74.89M | 35.08M |
| Total Liabilities | 21.94M | 94.35M | 60.5M | 49.3M | 47.36M |
| Total Equity | 33.48M | 65.22M | 34.29M | 20.47M | -12.27M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.33M | -3.83M | -9.81M | -15.36M | -20.71M |
| Investing | -932k | -24k | -215k | -302k | -512k |
| Financing | 12.19M | N/A | 9.85M | 9.59M | 20.43M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.98M | -35.94M | -45.57M | -23.33M | -20.71M |
| Investing | -11.75M | -13.96M | -4.34M | -932k | -512k |
| Financing | 22.8M | 78.36M | 35.81M | 12.19M | 20.43M |
| Market Cap | 62.63M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 8.39 |
| Price to Cash Ratio | 5.98 |
| Price to Book Ratio | -4.21 |
| Dividend Yield | - |
| Shares Outstanding | 16.84M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.19 (4.87%) |
| Company Name | OncoCyte Corporation |
| Address |
15 cushing irvine, california 92618 |
| Website | https://www.oncocyte.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
